NCT00709969 - Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria | Biotech Hunter

Enrollment

310

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

February 28, 2003

Conditions

Plasmodium Falciparum Malaria

Interventions

DRUG

Artemether-lumefantrine

20mg artemether and 120 mg lumefantrine, tablet, dose based on body weight, 3 days treatment 5 - \< 10kg (BWG 1) = 6 doses of 1 tablet / 10 - \< 15kg (BWG 2) = 6 doses of 1 tablet / 15 - ≤ 25kg (BWG 3) = 6 doses of 2 tablets

Trial Locations (3)

Unknown

Kemri-Wellcome Trust Programme, Kilifi

University College Hospital Malaria Research Laboratories Institute for Advance Medical Research and Training, Ibadan

Muhimbili University College of Health Sciences Department of Parasitology and Medical Entomology, Box 65011, Dar es Salaam